Autologous Fecal Microbiota Transplantation to Prevent Antibiotic Resistant Bacteria Colonization

Completed · Phase 1 · Has a placebo group

Conditions studied: Antibiotic Resistant Strain

In brief

This study, a Randomized controlled trial of Autologous microbiome reconstitution to prevent Colonization by antibiotic rEsistant bacteria (RACE), seeks to investigate the safety, feasibility and the role of autologous fecal microbiota transplantation (FMT) for the prevention of antibiotic resistant bacteria (ARB) through microbiome restoration.

Key facts

Study ID

NCT03061097

Run by

Microbiome Health Research Institute

People needed

7

Starts

2017-07-10

Expected to finish

2019-06-18

Last updated by the study team

2021-05-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

• Boston University - Boston Medical Center nursing home consortium — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.